<DOC>
	<DOCNO>NCT02446977</DOCNO>
	<brief_summary>Administration CBG000592 ( riboflavin/vitamin B2 ) patient acute ischemic stroke know cause reduction glutamate-mediated excitotoxicity .</brief_summary>
	<brief_title>Administration CBG000592 ( Riboflavin/Vitamin B2 ) Patients With Acute Ischemic Stroke</brief_title>
	<detailed_description>The investigator hypothesis focus effect riboflavin give first three hour ischemic stroke , reduce agent cerebral glutamate concentration . This administration would produce reduction excitotoxic damage consequently generate clinical improvement , low income well functional outcome patient three month .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Riboflavin</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>1 . Patients older 18 year , men woman . 2 . Patient legal representative able understand sign inform consent . 3 . Patients suspect stroke within 3 hour onset . 1 . Women childbearing age , potential pregnancy breastfeeding . 2 . Patients score ≥ 2 point 1a NIHSS scale . 3 . Scale prestroke modify Rankin ≥ 2 . 4 . Inability prior test image need study . 5 . Previous disorder may interfere interpretation neurological scale . 6 . Treatment probenecid , tricyclic antidepressant , phenothiazine , streptomycin , erythromycin , tyrothricin , tetracycline carbomycin , time inclusion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>ischemic</keyword>
	<keyword>stroke</keyword>
	<keyword>vitamin B2</keyword>
</DOC>